A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)

Summary

The purpose of this study is to investigate the safety and efficacy of long-term E0302 administration in patients with Amyotrophic Lateral Sclerosis (ALS).

Timeline

Start

2008-02

Primary completion

2017-03-31

Completion

2017-03-31

Publications

• Kaji R, Nishi Y, Ishida T, Takase T, Ueda T, Maeda T, Izumi Y; Methylcobalamin 762 study group. Clinical safety of ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis: Open-label extension of a phase 2/3 randomized controlled study. J Neurol Sci. 2026 Jan 15;480:125701. doi: 10.1016/j.jns.2025.125701. Epub 2025 Dec 18.

Drugs

Indications